The Department of Health, Disability and Ageing has commenced a research project examining Pharmaceutical Benefits Scheme (PBS) arrangements for medicines used to treat multiple myeloma.
The project will review current PBS restrictions, treatment pathways and relevant clinical evidence, and develop options for future consideration by the Pharmaceutical Benefits Advisory Committee (PBAC). Stakeholder consultation will occur as the project progresses.
Further information is available on the Medicines for Multiple Myeloma webpage.
If you have any questions about the project, please email PBSpostmarket@health.gov.au.